A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma
Clinical trial NCT02616965 · COMPLETED
Trial details
- NCT number
- NCT02616965
- Sponsor
- Fox Chase Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-22
- Primary completion
- 2022-08-08
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.